Miller School of Medicine could one day change the way people with atrial fibrillation are treated. Researchers at UM ...

Here’s what they found, plus some key limitations.

The absolute rate is still below 0.5%, in line with prior ablation studies, but the issue warrants monitoring, a researcher ...

Atrial fibrillation (AFib) is an irregular and often very rapid heart rhythm, also called an arrhythmia and can create blood clots in the heart, which can increase your risk of having a stroke by five ...

RAPIBLYK (R) is an ultra-short-acting, selective beta-1 adrenergic receptor blocker administered intravenously in a monitored hospital setting. Its pharmacological profile allows for rapid onset and ...

FDA approval for RAPIBLYK® (landiolol) for use in pediatric patients with SVT provides first therapeutic option for these ...

At 30 days, bleeding and pacemaker rates were lower than in TRISCEND II, but long-term outcomes are eagerly awaited.

By early detection of fluid in the lungs, a device allows early therapy adjustments to reduce all-cause mortality in patients ...

Patients with atherosclerotic cardiovascular disease who had received herpes zoster vaccination saw reductions in major ...

Cryopreserver Vitrafy has reported promising initial results from a follow-up blood platelet freezing trial with the US ...

View Adagio Medical Holdings, Inc ADGM stock quote prices, financial information, real-time forecasts, and company news from CNN.